After a video of him making a racist gesture toward a South Korean content creator during the 2026 FIFA World Cup went viral on social media, igniting a firestorm of condemnation and a broader ...

Update May 21: GitHub has now linked this breach to the TanStack npm supply-chain attack and says the employee installed a malicious version of the Nx Console extension. GitHub has confirmed that ...

Visual Studio Code Agents ships with VS Code Insiders, launches separately from the editor, and starts with its own sign-in, workspace selection, trust, and approval flow. In a real editorial ...

INO-3107’s review falls under the purview of Vinay Prasad, M.D., the outgoing director of the Center for Biologics Evaluation and Research who has faced scrutiny for rare disease rejections. (iStock / ...

CEO Jacqueline Shea highlighted that "these are very exciting times for Inovio with our first BLA for INO-3107 as a potential treatment for adults with recurrent respiratory papillomatosis or RRP, ...

First, for the good news. Inovio Pharmaceuticals is a fairly innovative company that develops DNA medicine, a type of therapy that gives patients' bodies the blueprint to produce specific immune ...

Baby Keem‘s long-awaited new album, Ca$ino, dropped on Friday and quickly took over the rap discourse online. As one of the first hotly anticipated releases of the ...

Baby Keem is releasing a new album this month. Ca$ino, which follows 2021’s The Melodic Blue, is due out February 20 via pgLang/Eerie Times/Columbia Records and ...

Inovio Pharmaceuticals is highly dependent on the regulatory outcome for INO-3107, its DNA-based therapeutic for recurrent respiratory papillomatosis (RRP). The FDA accepted the BLA for INO-3107 but ...

What if you could combine the simplicity of Arduino with the power of a Linux-based processor, all in one compact device? Enter the Arduino Uno Q, a new development board designed to handle everything ...

Inovio shares were 22% lower, at $1.80, after the company said the Food and Drug Administration accepted its Biologics License Application for INO-3107 for review as a potential treatment for adults ...

This story was originally published by The 19th. In the months leading up to his election, President Donald Trump insisted that he had nothing to do with the far-right vision for his second ...